Omega Therapeutics Inc (OMGA)
2.08
-0.16
(-7.14%)
USD |
NASDAQ |
Jun 28, 16:00
2.01
-0.07
(-3.37%)
After-Hours: 20:00
Omega Therapeutics Free Cash Flow: -78.61M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -78.61M |
| December 31, 2023 | -94.38M |
| September 30, 2023 | -100.71M |
| June 30, 2023 | -102.11M |
| March 31, 2023 | -104.50M |
| December 31, 2022 | -99.90M |
| September 30, 2022 | -91.52M |
| Date | Value |
|---|---|
| June 30, 2022 | -83.21M |
| March 31, 2022 | -71.98M |
| December 31, 2021 | -59.08M |
| September 30, 2021 | -51.74M |
| June 30, 2021 | -42.58M |
| March 31, 2021 | -32.74M |
| December 31, 2020 | -27.94M |
Free Cash Flow Range, Past 5 Years
-104.50M
Minimum
Mar 2023
-27.94M
Maximum
Dec 2020
-74.36M
Average
-80.91M
Median
Free Cash Flow Benchmarks
| Altimmune Inc | -72.76M |
| Macrogenics Inc | -113.88M |
| Viking Therapeutics Inc | -54.87M |
| vTv Therapeutics Inc | -21.25M |
| Rhythm Pharmaceuticals Inc | -140.47M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -11.80M |
| Cash from Investing (Quarterly) | 4.465M |
| Cash from Financing (Quarterly) | -1.07M |
| Free Cash Flow Per Share (Quarterly) | -0.2238 |
| Free Cash Flow to Equity (Quarterly) | -11.35M |
| Free Cash Flow Yield | -68.55% |